| EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies N Aide, C Lasnon, P Veit-Haibach, T Sera, B Sattler, R Boellaard European journal of nuclear medicine and molecular imaging 44, 17-31, 2017 | 267 | 2017 |
| Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients C Lasnon, C Desmonts, E Quak, R Gervais, P Do, C Dubos-Arvis, N Aide European journal of nuclear medicine and molecular imaging 40, 985-996, 2013 | 133 | 2013 |
| Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy N Aide, C Fruchart, C Nganoa, AC Gac, C Lasnon European radiology 30, 4623-4632, 2020 | 70 | 2020 |
| Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non–small cell lung cancer C Lasnon, RJ Hicks, JM Beauregard, A Milner, M Paciencia, AV Guizard, ... Clinical nuclear medicine 37 (10), 971-976, 2012 | 67 | 2012 |
| 18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer C Lasnon, M Majdoub, B Lavigne, P Do, J Madelaine, D Visvikis, M Hatt, ... European journal of nuclear medicine and molecular imaging 43, 2324-2335, 2016 | 58 | 2016 |
| Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma N Aide, M Talbot, C Fruchart, G Damaj, C Lasnon European journal of nuclear medicine and molecular imaging 45, 699-711, 2018 | 52 | 2018 |
| New PET technologies–embracing progress and pushing the limits N Aide, C Lasnon, A Kesner, CS Levin, I Buvat, A Iagaru, K Hermann, ... European journal of nuclear medicine and molecular imaging 48 (9), 2711-2726, 2021 | 42 | 2021 |
| Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction C Lasnon, T Salomon, C Desmonts, P Dô, Y Oulkhouir, J Madelaine, ... Annals of nuclear medicine 31, 125-134, 2017 | 41 | 2017 |
| Author gender inequality in medical imaging journals and the COVID-19 pandemic E Quak, G Girault, MA Thenint, K Weyts, J Lequesne, C Lasnon Radiology 300 (1), E301-E307, 2021 | 40 | 2021 |
| Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and … K Prigent, C Lasnon, E Ezine, M Janson, N Coudrais, E Joly, L Césaire, ... European journal of nuclear medicine and molecular imaging 48, 2573-2585, 2021 | 35 | 2021 |
| Does PET SUV harmonization affect PERCIST response classification? E Quak, PY Le Roux, C Lasnon, P Robin, MS Hofman, D Bourhis, ... Journal of Nuclear Medicine 57 (11), 1699-1706, 2016 | 35 | 2016 |
| Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer B Houdu, C Lasnon, I Licaj, G Thomas, P Do, AV Guizard, C Desmonts, ... European journal of nuclear medicine and molecular imaging 46, 421-428, 2019 | 34 | 2019 |
| Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs) C Lasnon, B Enilorac, H Popotte, N Aide EJNMMI research 7, 1-9, 2017 | 34 | 2017 |
| Does PET reconstruction method affect Deauville score in lymphoma patients? B Enilorac, C Lasnon, C Nganoa, C Fruchart, AC Gac, G Damaj, N Aide Journal of Nuclear Medicine 59 (7), 1049-1055, 2018 | 32 | 2018 |
| The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria E Quak, N Hovhannisyan, C Lasnon, C Fruchart, JP Vilque, D Musafiri, ... Haematologica 99 (6), e84, 2014 | 29 | 2014 |
| Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics N Aide, T Salomon, C Blanc-Fournier, JM Grellard, C Levy, C Lasnon EJNMMI research 8, 1-11, 2018 | 27 | 2018 |
| How fast can we scan patients with modern (digital) PET/CT systems? C Lasnon, N Coudrais, B Houdu, C Nganoa, T Salomon, B Enilorac, ... European Journal of Radiology 129, 109144, 2020 | 23 | 2020 |
| Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT K Weyts, C Lasnon, R Ciappuccini, J Lequesne, A Corroyer-Dulmont, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 3750-3760, 2022 | 22 | 2022 |
| Advances in PET/CT technology: an update N Aide, C Lasnon, C Desmonts, IS Armstrong, MD Walker, DR McGowan Seminars in nuclear medicine 52 (3), 286-301, 2022 | 21 | 2022 |
| Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2 E Quak, A Lasne Cardon, R Ciappuccini, C Lasnon, V Bastit, V Le Henaff, ... BMC endocrine disorders 21, 1-7, 2021 | 21 | 2021 |
Professor Rod HicksDepartment of Medicine, St Vincent's Hospital, the University of Melbourne and Department ofVerified email at mtic.net.au
